Published in Antimicrob Agents Chemother on March 01, 1976
Susceptibility of anaerobic bacteria to 23 antimicrobial agents. Antimicrob Agents Chemother (1976) 9.53
Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides. Antimicrob Agents Chemother (1988) 3.21
Medium for selective isolation of Fusobacterium nucleatum from human periodontal pockets. J Clin Microbiol (1979) 1.63
Comparative pharmacology of josamycin and erythromycin stearate. Antimicrob Agents Chemother (1976) 1.46
In vitro activity of rosamicin, josamycin, erythromycin, and clindamycin against beta-lactamase-nagative and beta-lactamase-positive strains of Neisseria gonorrhoeae. Antimicrob Agents Chemother (1979) 1.46
Comparison of josamycin and erythromycin in the therapy of Mycoplasma pneumoniae pneumonia. Antimicrob Agents Chemother (1976) 1.09
In vitro activity of josamycin and rosamicin against Bacteroides fragilis compared with clindamycin, erythromycin, and metronidazole. Antimicrob Agents Chemother (1976) 1.02
In vivo effects of josamycin, erythromycin, and placebo therapy on nasal carriage of Staphylococcus aureus. Antimicrob Agents Chemother (1977) 0.86
In vitro susceptibility of common clinical anaerobic and aerobic isolates against josamycin. Antimicrob Agents Chemother (1976) 0.83
Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA (1997) 8.24
Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis. JAMA (1998) 8.02
Social ties and susceptibility to the common cold. JAMA (1997) 7.08
Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N Engl J Med (1992) 6.30
Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med (1989) 6.29
A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis. N Engl J Med (1979) 5.87
Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA (1989) 5.66
Effect of probenecid on cerebrospinal fluid concentrations of penicillin and cephalosporin derivatives. Antimicrob Agents Chemother (1974) 5.19
Sexual harassment in medical training. N Engl J Med (1993) 4.93
Species-specific resistance to antimocrobial synergism in Streptococcus faecium and Streptococcus faecalis. J Infect Dis (1979) 4.70
Bacterial adherence in the pathogenesis of endocarditis. Interaction of bacterial dextran, platelets, and fibrin. J Clin Invest (1978) 4.38
Role of toxigenic and invasive bacteria in acute diarrhea of childhood. N Engl J Med (1975) 4.23
Principles of appropriate antibiotic use for acute pharyngitis in adults: background. Ann Intern Med (2001) 3.75
Antimicrobial therapy of experimental endocarditis caused by Staphylococcus aureus. J Infect Dis (1975) 3.52
Spread of Streptococcus pneumoniae in families. I. Carriage rates and distribution of types. J Infect Dis (1975) 3.33
Epidemic Rift Valley fever in Egypt: observations of the spectrum of human illness. Trans R Soc Trop Med Hyg (1979) 3.23
Principles of appropriate antibiotic use for acute rhinosinusitis in adults: background. Ann Intern Med (2001) 3.15
Combination antibiotic therapy of bacterial endocarditis. Ann Intern Med (1980) 3.03
Excessive antibiotic use for acute respiratory infections in the United States. Clin Infect Dis (2001) 2.87
Zoster sine herpete, a clinical variant. Ann Neurol (1994) 2.84
Transmission of rhinovirus colds by self-inoculation. N Engl J Med (1973) 2.80
Endocarditis due to methicillin-resistant Staphylococcus aureus in rabbits: expression of resistance to beta-lactam antibiotics in vivo and in vitro. J Infect Dis (1984) 2.77
Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N Engl J Med (1991) 2.77
A cloud adult: the Staphylococcus aureus-virus interaction revisited. Ann Intern Med (1996) 2.66
Penicillin-aminoglycoside synergy in experimental Streptococcus viridans endocarditis. J Infect Dis (1974) 2.64
Community-acquired bacteremia in patients with acquired immunodeficiency syndrome: clinical presentation, bacteriology, and outcome. Am J Med (1989) 2.58
Sinusitis of the maxillary antrum. N Engl J Med (1975) 2.57
Diagnosis and management of group A streptococcal pharyngitis: a practice guideline. Infectious Diseases Society of America. Clin Infect Dis (1997) 2.54
Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: A prospective study. Ann Intern Med (1982) 2.52
Types of stressors that increase susceptibility to the common cold in healthy adults. Health Psychol (1998) 2.47
Hand-to-hand transmission of rhinovirus colds. Ann Intern Med (1978) 2.46
Attachment and ingestion of gonococci human neutrophils. Infect Immun (1975) 2.43
Risk of transmitting the human immunodeficiency virus, cytomegalovirus, and hepatitis B virus to health care workers exposed to patients with AIDS and AIDS-related conditions. J Infect Dis (1987) 2.32
Rhinovirus infections in an industrial population. I. The occurrence of illness. N Engl J Med (1966) 2.27
Treatment of right-sided Staphylococcus aureus endocarditis in intravenous drug users with ciprofloxacin and rifampicin. Lancet (1989) 2.18
Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: background, specific aims, and methods. Ann Intern Med (2001) 2.17
Temperature-sensitive mutants of influenza A virus. XII. Safety, antigenicity, transmissibility, and efficacy of influenza A/Udorn/72-ts-1[E] recombinant viruses in human adults. J Infect Dis (1976) 2.12
Infectious complications with respiratory pathogens despite ciprofloxacin therapy. N Engl J Med (1991) 2.12
Infections and antibiotic resistance in nursing homes. Clin Microbiol Rev (1996) 2.10
Effects of ampicillin and corticosteroids on brain water content, cerebrospinal fluid pressure, and cerebrospinal fluid lactate levels in experimental pneumococcal meningitis. J Infect Dis (1985) 2.10
A collaborative report: rhinoviruses--extension of the numbering system from 89 to 100. Virology (1987) 2.10
Natural history of disseminated Mycobacterium avium complex infection in AIDS. J Infect Dis (1991) 2.07
The HIV epidemic and training in internal medicine. Challenges and recommendations. N Engl J Med (1989) 2.06
Uncomplicated acute bronchitis. Ann Intern Med (2000) 2.06
Spread of Streptococcus pneumoniae in families. II. Relation of transfer of S. pneumoniae to incidence of colds and serum antibody. J Infect Dis (1975) 2.05
A randomized comparison of the safety and efficacy of once-daily gentamicin or thrice-daily gentamicin in combination with ticarcillin-clavulanate. Am J Med (1998) 2.04
Antimicrobial treatment of infective endocarditis due to viridans streptococci, enterococci, and staphylococci. JAMA (1989) 2.03
Antibacterial activity of beta-lactam antibiotics in experimental meningitis due to Streptococcus pneumoniae. J Infect Dis (1984) 2.00
Comparative toxicity of amantadine hydrochloride and rimantadine hydrochloride in healthy adults. Antimicrob Agents Chemother (1981) 1.99
Methods to improve detection of pneumococci in respiratory secretions. J Clin Microbiol (1975) 1.94
Bactericidal versus bacteriostatic antibiotic therapy of experimental pneumococcal meningitis in rabbits. J Clin Invest (1983) 1.93
Single, large, daily dosing versus intermittent dosing of tobramycin for treating experimental pseudomonas pneumonia. J Infect Dis (1988) 1.90
Role of the vegetation in experimental Streptococcus viridans endocarditis. Infect Immun (1974) 1.89
Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults: background. Ann Intern Med (2001) 1.89
Multiple use of disposable insulin syringe-needle units. JAMA (1980) 1.89
Therapy of cryptococcosis with a combination of flucytosine and amphotericin B. J Infect Dis (1975) 1.88
Routine use of anaerobic blood cultures: are they still indicated? Am J Med (2000) 1.88
Effect of inhalation of hot humidified air on experimental rhinovirus infection. JAMA (1994) 1.87
Comparative pharmacology of cefaclor and cephalexin. Antimicrob Agents Chemother (1977) 1.86
Pefloxacin therapy for experimental endocarditis caused by methicillin-susceptible or methicillin-resistant strains of Staphylococcus aureus. Antimicrob Agents Chemother (1985) 1.85
Opportunistic pneumonia: a clinicopathological study of five cases caused by an unidentified acid-fast bacterium. N Engl J Med (1979) 1.84
Alteration of cerebrospinal fluid findings by partial treatment of bacterial meningitis. J Pediatr (1973) 1.77
Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or -resistant Staphylococcus aureus. Antimicrob Agents Chemother (1984) 1.75
Antimicrobial therapy of experimental enterococcal endocarditis. Antimicrob Agents Chemother (1975) 1.75
Nafcillin-gentamicin synergism in experimental staphylococcal endocarditis. J Lab Clin Med (1976) 1.73
Experimental pneumococcal meningitis: role of leukocytes in pathogenesis. Infect Immun (1983) 1.72
Serum bactericidal activity of rifampin in combination with other antimicrobial agents against Staphylococcus aureus. Antimicrob Agents Chemother (1986) 1.70
Cephalosporin antibiotics in therapy of experimental Streptococcus pneumoniae and Haemophilus influenzae meningitis in rabbits. J Infect Dis (1978) 1.68
The postantibiotic effect in the treatment of experimental meningitis caused by Streptococcus pneumoniae in rabbits. J Infect Dis (1984) 1.67
Candida albicans endocarditis: ultrastructural studies of vegetation formation. Infect Immun (1978) 1.66
Failure of a once-daily regimen of cefonicid for treatment of endocarditis due to Staphylococcus aureus. Rev Infect Dis (1985) 1.66
Pharmacokinetics of cefoperazone in normal volunteers and subjects with renal insufficiency. Antimicrob Agents Chemother (1981) 1.66
New cephalosporins cefotaxime, cefpimizole, BMY 28142, and HR 810 in experimental pneumococcal meningitis in rabbits. Antimicrob Agents Chemother (1985) 1.66
Rhinoviruses. Yale J Biol Med (1975) 1.66
Treatment of streptomycin-susceptible and streptomycin-resistant enterococcal endocarditis. Ann Intern Med (1984) 1.64
Cerebrospinal fluid outflow resistance in rabbits with experimental meningitis. Alterations with penicillin and methylprednisolone. J Clin Invest (1980) 1.64
Serologic responses and systemic reactions in adults after vaccination with monovalent A/USSR/77 and trivalent A/USSR/77, A/Texas/77, B/Hong Kong/72 influenza vaccines. Rev Infect Dis (1983) 1.64
Rapid diagnosis of lymphocytic meningitis by frequency-pulsed electron capture gas-liquid chromatography: differentiation of tuberculous, cryptococcal, and viral meningitis. J Clin Microbiol (1977) 1.63
Coronavirus infections in military recruits. Three-year study with coronavirus strains OC43 and 229E. Am Rev Respir Dis (1974) 1.62
Response to therapy in an experimental rabbit model of meningitis due to Listeria monocytogenes. J Infect Dis (1979) 1.57
Prevention of natural colds by contact prophylaxis with intranasal alpha 2-interferon. N Engl J Med (1986) 1.56
Experimental Candida albicans endocarditis: characterization of the disease and response to therapy. Infect Immun (1977) 1.56
Value of serum tests in combined drug therapy of endocarditis. Antimicrob Agents Chemother (1983) 1.56
Principles of appropriate antibiotic use for treatment of uncomplicated acute bronchitis: background. Ann Intern Med (2001) 1.55
A comparison of subcutaneous, nasal, and combined influenza vaccination. II. Protection against natural challenge. Am J Epidemiol (1971) 1.54
Sustained bacteremia in patients with prosthetic cardiac valves. N Engl J Med (1972) 1.54
Etiology and antimicrobial therapy of acute maxillary sinusitis. J Infect Dis (1979) 1.52
Moxalactam and cefazolin: comparative pharmacokinetics in normal subjects. Antimicrob Agents Chemother (1981) 1.51
In vitro susceptibility studies with cefaclor and cephalexin. Antimicrob Agents Chemother (1977) 1.51
Intermittent or continuous therapy of experimental meningitis due to Streptococcus pneumoniae in rabbits: preliminary observations on the postantibiotic effect in vivo. Rev Infect Dis (1981) 1.49
Two randomized controlled trials of zinc gluconate lozenge therapy of experimentally induced rhinovirus colds. Antimicrob Agents Chemother (1987) 1.49
Accuracy of Gram's stain in identifying pneumococci in sputum. JAMA (1978) 1.48
Interruption of experimental rhinovirus transmission. J Infect Dis (1980) 1.47